Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Torrey Pines Medicine secures an angel round led by Lotus Lake Capital to raise tens of millions of RMB for its ultra-long-acting peptide therapeutics. The funding will expedite the development of TPM004 and the PepTetris™ platform.
Amount Raised
¥10 Million
Round Type
Seed
ShenzhenBiotechnologyHealth CareTherapeuticsInvestors
Description
Torrey Pines Medicine has successfully completed an angel financing round raising tens of millions of RMB to advance its peptide therapeutics. The round was led by Lotus Lake Ventures, with participation from Stars Capital, Tainuo Capital, and Blue Ocean Capital. The proceeds will support IND filing and clinical trials for TPM004 and refine the PepTetris™ platform. The company's focus remains on addressing unmet clinical needs in metabolic diseases.
Funding Insights
Based on industry dataWatching Torrey Pines Medicine? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan